ViewRay Systems, Inc. (VRAYQ)

Market Cap	183.00 -99.0%
Revenue (ttm)	105.86M +44.1%
Net Income	-110.42M
EPS	-0.61
Shares Out	183.40M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200
Average Volume	13,744
Open	0.0000
Previous Close	n/a
Day's Range	0.0000 - 0.0000
52-Week Range	n/a
Beta	-25.12
RSI	48.16
Earnings Date	n/a

About ViewRay Systems

ViewRay Systems, Inc. designs, manufactures, and markets magnetic resonance imaging radiation therapy system in the United States and internationally. The company offers MRIdian A3i, an MRI-guided radiation therapy system that provides real-time 3D tissue tracking and automated beam control. Its product is used for the treatment of pancreas, prostate, lung, liver, breast, and oligometastatic cancers. The company was founded in 2004 and is headquartered in Oakwood, Ohio. On July 16, 2023, ViewRay, Inc., along with its affiliate, filed a voluntar...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 295
• Stock Exchange: OTCMKTS
• Ticker Symbol: VRAYQ

Financial Performance

In 2022, ViewRay Systems's revenue was $102.21 million, an increase of 45.76% compared to the previous year's $70.12 million. Losses were -$107.33 million, -2.47% less than in 2021.